Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Active, Not Recruiting

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

NCT05471843

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL

NCT04624958

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

NCT05214183

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Department of Hematology X, Odense University Hospital Odense, Denmark
  • Department of Hematology, Zeeland University Hospital Roskilde Roskilde, Denmark
  • Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center Helsinki, Finland
  • Oulu University Hospital Oulu, Finland
View all 20 locations
View Trial Details
Active, Not Recruiting

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma

NCT04718883

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Consonancy Hospital Fuzhou, Fujiang, China
  • Guangdong Province people hospital Guanzhou, Guangdong, China
View Trial Details

Related conditions